Genentech
TECENTRIQ
Manufacturer:
Genentech
Name:
TECENTRIQ
Category:
J Code
HCPCS:
J9022
NDC(s):
50242-0917-01, 50242-0918-01,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
TECENTRIQ is a Cancer drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9022 is aligned to the drug TECENTRIQ.